Nanotechnology – a robust tool for fighting the challenges of drug resistance in non-small cell lung cancer

Genomic and proteomic mutation analysis is the standard of care for selecting candidates for therapies with tyrosine kinase inhibitors against the human epidermal growth factor receptor (EGFR TKI therapies) and further monitoring cancer treatment efficacy and cancer development. Acquired resistance...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorachinov, Filip, Mraiche, Fatima, Moustafa, Diala Alhaj, Hishari, Ola, Ismail, Yomna, Joseph, Jensa, Crcarevska, Maja Simonoska, Dodov, Marija Glavas, Geskovski, Nikola, Goracinova, Katerina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Beilstein-Institut 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972888/
https://www.ncbi.nlm.nih.gov/pubmed/36865093
http://dx.doi.org/10.3762/bjnano.14.23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972888/
https://www.ncbi.nlm.nih.gov/pubmed/36865093
http://dx.doi.org/10.3762/bjnano.14.23

Ejemplares similares